Skip to main content

Table 1 Antibacterial activity of processed AF against ESKAPE pathogens

From: Processed human amniotic fluid retains its antibacterial activity

Lot #

E. aerogenes

S. aureus

K. pneumoniae

A. baumannii

P. aeruginosa

E. faecium

1

7.2 ± 0.1

8.7 ± 0.0

5.5 ± 0.1

3.3 ± 0.1

5.5 ± 0.2

2.3 ± 0.2

2

6.8 ± 0.0

4.7 ± 0.4

4.8 ± 0.3

5.2 ± 0.1

5.5 ± 0.1

2.6 ± 0.1

3

7.7 ± 0.6

8.7 ± 0.0

0.9 ± 0.0

4.8 ± 0.1

2.0 ± 0.1

9.2 ± 0.0

4

7.5 ± 0.1

8.7 ± 0.0

4.8 ± 0.7

3.7 ± 0.1

5.5 ± 0.1

2.4 ± 0.1

5

0.7 ± 0.1

8.7 ± 0.0

0.6 ± 0.1

0.8 ± 0.0

0.5 ± 0.1

1.8 ± 0.1

6

7.6 ± 0.2

8.7 ± 0.0

4.4 ± 0.4

5.0 ± 0.1

5.4 ± 0.1

3.0 ± 0.2

  1. Expressed as a log reduction in growth against each bacterium; Log reduction = Log10 CFU(Ctrl) − Log10 CFU(AF)